# Nuclide record psma-pet (technology). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/technologies/psma-pet/>
  a schema:MedicalTherapy ;
  nuclide:kind "technology" ;
  schema:identifier "psma-pet" ;
  schema:name "PSMA PET"@en ;
  schema:description "A prostate-cancer-specific PET scan that finds spread far earlier than CT or bone scan, and tells you whether a matched radioactive drug will work."@en ;
  schema:url <https://nuclide.cc/technologies/psma-pet/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2107322>, <https://clinicaltrials.gov/study/NCT03392428> ;
  nuclide:status "standard-of-care" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet/>, <https://nuclide.cc/technologies/radioligand-therapy/> ;
  nuclide:targets <https://nuclide.cc/targets/psma/> ;
  nuclide:drugs <https://nuclide.cc/drugs/choline-c11/> ;
  nuclide:companies <https://nuclide.cc/companies/clarity-pharmaceuticals/> ;
  nuclide:trials <https://nuclide.cc/trials/pop-rt/> ;
  nuclide:dependsOn <https://nuclide.cc/technologies/pet-ct/>, <https://nuclide.cc/technologies/radiopharmacy-network/> .